ILLUMINA, INC. for ILLUMINA, INC.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Oct 21, 2024 | $260,000 | Replaced |
| 3rd Quarter - Amendment (this page) | Dec 12, 2024 | $280,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 2369: VALID Act of 2023; provisions related to the the Food and Drug Administration's Laboratory Developed Tests (LDT) Rule and regulation of diagnostics and lab developed tests H.R. 2407: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; provisions related to coverage of Multi-Cancer Early Detection (MCED) tests General discussions related to the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICOLAS MAGALLANES | — |
Defense DEF
H.R. 8333: BIOSECURE Act; provisions related to genomics issues pertaining to national security
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICOLAS MAGALLANES | — |
Budget/Appropriations BUD
H.R. 9747: Continuing Appropriations and Extensions Act, 2025; provisions related to government funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICOLAS MAGALLANES | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.